Showing results (2671-2680 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 23, 2013
Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapySaly Al-Taei, Russell Banner, Ned Powell, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2013
Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patientsKimberly R Jordan, Rodabe N Amaria, Oscar Ramirez, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2013
Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinomaQiu-Zhong Pan, Ke Pan, Jing-Jing Zhao, et al.
Cancer Immunology, Immunotherapy : CII|September 21, 2013
Antitumor immune responses induced by ionizing irradiation and further immune stimulationBenjamin Frey, Yvonne Rubner, Lorenz Kulzer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sourcesS K Gregorian, J R Battisto
Cancer Immunology, Immunotherapy : CII|March 20, 2012
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trialEva Ellebaek, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2011
Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumorsHideyuki Nakashima, Kotaro Miyake, Christopher R Clark, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2015
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastomaElias J Sayour, Pat McLendon, Roger McLendon, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2014
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Dan P Zandberg, Sandra Rollins, Olga Goloubeva, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2014
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanomaAnne Helene Køstner, Mai-Britt Bjørklund Ellegaard, Ib Jarle Christensen, et al.
Pageof 652